Beneficial Effect of Sirolimus-Pretreated Mesenchymal Stem Cell Implantation on Diabetic Retinopathy in Rats
Background: Diabetic retinopathy (DR) is a vision-threatening complication that affects virtually all diabetic patients. Various treatments have been attempted, but they have many side effects and limitations. Alternatively, stem cell therapy is being actively researched, but it faces challenges due...
Main Authors: | Nanyoung Kang, Ji Seung Jung, Jiyi Hwang, Sang-Eun Park, Myeongjee Kwon, Haerin Yoon, Jungyeon Yong, Heung-Myong Woo, Kyung-Mee Park |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/2/383 |
Similar Items
-
Subconjunctival Delivery of Sorafenib-Tosylate-Loaded Cubosomes for Facilitated Diabetic Retinopathy Treatment: Formulation Development, Evaluation, Pharmacokinetic and Pharmacodynamic (PKPD) Studies
by: Sharadha Madhusudhan, et al.
Published: (2023-10-01) -
Safety of a novel VEGF-target antibody's ocular application
by: Qun Wang, et al.
Published: (2017-11-01) -
Lymphedema attributed to sirolimus
by: Ardalan Mohammad-Reza
Published: (2013-04-01) -
Pancreatic Kaposiform Hemangioendothelioma Not Responding to Sirolimus
by: Paloma Junco Triana, et al.
Published: (2017-01-01) -
Effects of sirolimus on Lung function in patients with Lymphangioleiomyomatosis
by: Fatemeh Aghaeimeybodi, et al.
Published: (2019-01-01)